Literature DB >> 16552047

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.

Lisa M Ganley-Leal1, Pauline N Mwinzi, Catherine B Cetre-Sossah, Julius Andove, Allen W Hightower, Diana M S Karanja, Daniel G Colley, W Evan Secor.   

Abstract

Longitudinal investigations of an adult male population of Kenyan car washers who have heavy and quantifiable occupational exposure to Schistosoma mansoni cercariae revealed that some individuals develop resistance to reinfection while others remain highly susceptible. We sought to characterize immune correlates associated with host protection in this population. Previous studies have demonstrated an association of peripheral eosinophilia with resistance to reinfection with schistosomes. Thus, we investigated the relationship between the percentage of circulating eosinophils and the effect of human immunodeficiency virus type 1 (HIV-1) coinfection on the susceptibility of the car washers to reinfection with schistosomes. Elevated percentages of circulating eosinophils were associated with resistance to reinfection by S. mansoni in HIV-1-seronegative persons. In the HIV-1-seropositive cohort, low CD4+-T-cell counts were associated with a less intense eosinophilia. Moreover, eosinophils from the car washers expressed high levels of FcepsilonRI beta chain, a molecule important in immunoglobulin E (IgE)-mediated immunity. Levels of FcepsilonRI beta chain expression correlated with serum levels of total and antigen-specific IgE for HIV-1-negative car washers, but this was not the case for individuals coinfected with HIV-1. Overall, these data further implicate eosinophils as having a potential role in development of protective immunity against schistosomes and suggest that changes associated with HIV-1 coinfection increase susceptibility to reinfection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552047      PMCID: PMC1418888          DOI: 10.1128/IAI.74.4.2169-2176.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.

Authors:  J P Kinet
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation.

Authors:  H Kayaba; D Dombrowicz; G Woerly; J P Papin; S Loiseau; M Capron
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI.

Authors:  T A Borkowski; M H Jouvin; S Y Lin; J P Kinet
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 4.  Mechanisms of IgE elevation in HIV-1 infection.

Authors:  G Marone; G Florio; M Triggiani; A Petraroli; A de Paulis
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

5.  Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4.

Authors:  Y Li; L Li; R Wadley; S W Reddel; J C Qi; C Archis; A Collins; E Clark; M Cooley; S Kouts; H M Naif; M Alali; A Cunningham; G W Wong; R L Stevens; S A Krilis
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

Review 6.  Dysregulation of the IgE/Fc epsilon RI network in HIV-1 infection.

Authors:  G Marone; G Florio; A Petraroli; A de Paulis
Journal:  J Allergy Clin Immunol       Date:  2001-01       Impact factor: 10.793

7.  Regulation of surface FcepsilonRI expression on human eosinophils by IL-4 and IgE.

Authors:  M Iikura; M Yamaguchi; K Hirai; M Miyamasu; H Yamada; T Nakajima; T Fujisawa; C Ra; Y Morita; K Yamamoto
Journal:  Int Arch Allergy Immunol       Date:  2001-04       Impact factor: 2.749

8.  Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils.

Authors:  S S Saini; J J Richardson; C Wofsy; S Lavens-Phillips; B S Bochner; D W Macglashan
Journal:  J Allergy Clin Immunol       Date:  2001-05       Impact factor: 10.793

9.  CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.

Authors:  S Horie; H Kita
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

10.  High-affinity IgE receptor on eosinophils is involved in defence against parasites.

Authors:  A S Gounni; B Lamkhioued; K Ochiai; Y Tanaka; E Delaporte; A Capron; J P Kinet; M Capron
Journal:  Nature       Date:  1994-01-13       Impact factor: 49.962

View more
  41 in total

1.  Toward the Proteome of the Human Peripheral Blood Eosinophil.

Authors:  Christof Straub; Konrad Pazdrak; Travis W Young; Susan J Stafford; Zheng Wu; John E Wiktorowicz; Anthony M Haag; Robert D English; Kizhake V Soman; Alexander Kurosky
Journal:  Proteomics Clin Appl       Date:  2009       Impact factor: 3.494

2.  Immuno-evasive tactics by schistosomes identify an effective allergy preventative.

Authors:  Qyana Griffith; YanMei Liang; Patrick Whitworth; Carlos Rodriguez-Russo; Ahmad Gul; Afzal A Siddiqui; John Connor; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Exp Parasitol       Date:  2015-03-24       Impact factor: 2.011

3.  CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells.

Authors:  Daniel Onguru; YanMei Liang; Jennifer Elliot; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

4.  Association of Schistosomiasis and HIV infection in Tanzania.

Authors:  Jennifer A Downs; Govert J van Dam; John M Changalucha; Paul L A M Corstjens; Robert N Peck; Claudia J de Dood; Heejung Bang; Aura Andreasen; Samuel E Kalluvya; Lisette van Lieshout; Warren D Johnson; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

5.  Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.

Authors:  Pauline N M Mwinzi; Lisa Ganley-Leal; Carla L Black; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

Review 6.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 7.  Urinary schistosomiasis.

Authors:  Oluwatoyin F Bamgbola
Journal:  Pediatr Nephrol       Date:  2014-01-28       Impact factor: 3.714

8.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

9.  Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection.

Authors:  Lucia A de Oliveira Fraga; Erika W Lamb; Elizabeth C Moreno; Mitali Chatterjee; Jan Dvořák; Melaine Delcroix; Mohammed Sajid; Conor R Caffrey; Stephen J Davies
Journal:  BMC Immunol       Date:  2010-11-15       Impact factor: 3.615

Review 10.  Protective immune mechanisms in helminth infection.

Authors:  Robert M Anthony; Laura I Rutitzky; Joseph F Urban; Miguel J Stadecker; William C Gause
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.